Adam Walker

Adam Walker is an accomplished professional with extensive experience in regulatory affairs and biopharmaceutical development. Currently serving as the Director of Regulatory Affairs CMC at BioNTech SE since February 2024, Adam previously held the position of Principal Consultant at Scendea for a brief period. Adam's career at GSK spanned over 16 years, where roles included Director of Biopharm CMC Global Regulatory Affairs, Manager in the same department, and various positions in clinical research and development, contributing to projects in cell and gene therapy, non-communicable diseases, and anti-inflammatory medicines. Adam began expertise in the field at Domantis as a Scientist I and has a solid educational background, holding a PhD in Cell Biology from the University of Cambridge and a BSc(Hons) in Microbiology from the University of Birmingham.